Insulin-Like Growth Factor Binding Protein 3
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Insulin-Like Growth Factor Binding Protein 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D018972
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D12.776.157.420.270 
						 | 
					
					
						| Concept/Terms | 
						
							
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Insulin-Like Growth Factor Binding Protein 3".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Insulin-Like Growth Factor Binding Protein 3".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in this website by year, and whether "Insulin-Like Growth Factor Binding Protein 3" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2004 | 1 | 0 | 1 | 
| 2005 | 0 | 1 | 1 | 
| 2008 | 0 | 2 | 2 | 
| 2011 | 0 | 2 | 2 | 
| 2019 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in Profiles.
						
					
								- 
								
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Gastroenterology. 2020 04; 158(5):1300-1312.e20.
															
								 
							
								- 
								
Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study. Eur J Clin Nutr. 2012 Oct; 66(10):1146-52.
															
								 
							
								- 
								
The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res Treat. 2012 Jan; 131(1):255-65.
															
								 
							
								- 
								
Computational analysis of simulated SNP interactions between 26 growth factor-related genes in a breast cancer association study. OMICS. 2011 Jun; 15(6):399-407.
															
								 
							
								- 
								
IGF1 and risk of additional breast cancer in the WHEL study. Endocr Relat Cancer. 2011 Apr; 18(2):235-44.
															
								 
							
								- 
								
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet. 2010 Aug 01; 19(15):3089-101.
															
								 
							
								- 
								
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res. 2010 Mar 15; 70(6):2389-96.
															
								 
							
								- 
								
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med. 2008 Oct 07; 149(7):461-71, W83-8.
															
								 
							
								- 
								
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One. 2008 Jul 02; 3(7):e2578.
															
								 
							
								- 
								
Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer. 2008 Apr 01; 122(7):1611-7.